Trial · NCT07882108
Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease
NCT07882108, Not applicable, Recruiting, Cambridge University Hospitals NHS Foundation Trust
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease. Trials, record NCT07882108. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882108
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease
- NCT number
- NCT07882108
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 72 participants, estimated
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Conditions
- REM Sleep Behavior Disorder, Parkinson s Disease
- Interventions
- Ginger
- First posted
- 2026-10-20
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in fasting blood acylated and unacylated ghrelin levels in PD, RBD and controls over 12 weeks of ginger supplementation. | Baseline - 12 weeks | |
| Secondary | Tolerability - compliance measured by self-recorded supplement diary and capsule counts. | Baseline - 12 weeks | |
| Secondary | Change in fasting blood acylated and unacylated ghrelin levels in PD, RBD and controls at 16 weeks (4 weeks post cessation of ginger supplements) | Baseline - 16 weeks | |
| Secondary | Change in levels of blood inflammatory markers (TNF-α, IL-6, IL-17, IL-1β, CRP, IFN-γ, neutrophil:lymphocyte ratio, systemic inflammatory index) | Baseline - 12 weeks, 16 weeks | |
| Secondary | Change in blood levels of gut enzymes/hormones (including but not limited to Ghrelin-O-Acyltransferase, IGF-1, GLP-1). | Baseline - 12 weeks, 16 weeks | |
| Other | Change in objective measures of gut function including whole gut transit time and methane breath tests. | Baseline - 12 weeks | |
| Other | Change in self-reported gut symptoms assessed using the Gastrointestinal Dysfunction in PD scale (GIDS-PD) | Baseline - 12 weeks, 16 weeks | |
| Other | Change in MDS-UPDRS parts I, II, III, IV (PD and RBD participants only). | Baseline - 12 weeks | |
| Other | Change in MoCA score | Baseline - 12 weeks | |
| Other | Change in semantic fluency score | Baseline - 12 weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as |
|---|---|
| Category Fluency | Other outcome |
Source ConductCognition
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882108
GET https://conductscience.org/api/trials/v1/NCT07882108/registered